Policy Tracker · Country overview

United States

A bill to change the law is under consideration.

Pending billShow on the map US states map How this status was decided Bill Tracker Canada, EU & other countries

National law

21 CFR 1308.11 — Schedule I (Controlled Substances Act, 21 U.S.C. 812)

ecfr.gov · Law

Laws by substance

"No record" means nothing has been verified yet, not that the substance is legal. Regional entries are labelled with their place.

Psychedelics

Pending bill

Pending: HB9559 — IBOGAINE Act Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act (In Committee).

No reviewed history yet.

Show on the Psychedelics map

Cannabis

Regulated framework

1939 · Minnesota
Marijuana possession prohibition baseline
Prohibited
Official source
1967 · Vermont
Controlled-substances prohibition baseline
Prohibited
Official source
1967 · Connecticut
Drug possession prohibition (PA 555)
Prohibited
Official source
1970 · South Dakota
Controlled-substances prohibition baseline
Prohibited
Official source
1970 · Virginia
Controlled-substances prohibition baseline
Prohibited
Official source
1970 · New Jersey
State controlled-substances prohibition
Prohibited
Official source
1970 · Maryland
State controlled-substances prohibition
Prohibited
Official source
27 Oct 1970
Controlled Substances Act
Prohibited
Official source
1971 · Missouri
Controlled substances scheduling baseline
Prohibited
Official source
1971 · Wyoming
Controlled-substances prohibition baseline
Prohibited
Official source
1971 · Utah
Controlled-substances prohibition baseline
Prohibited
Official source
1971 · Washington
Controlled-substances prohibition baseline
Prohibited
Official source
1971 · South Carolina
Controlled-substances prohibition baseline
Prohibited
Official source
1971 · West Virginia
Controlled-substances prohibition baseline
Prohibited
Official source
1971 · Tennessee
Controlled-substances prohibition baseline
Prohibited
Official source
1971 · Massachusetts
State controlled-substances prohibition
Prohibited
Official source
1971 · Illinois
State controlled-substances prohibition
Prohibited
Official source
1971 · Iowa
State controlled-substances prohibition
Prohibited
Official source
1971 · Alabama
State controlled-substances prohibition
Prohibited
Official source
1971 · Arkansas
State controlled-substances prohibition
Prohibited
Official source
1971 · North Carolina
State controlled-substances prohibition
Prohibited
Official source
1971 · Idaho
State controlled-substances prohibition
Prohibited
Official source
30 Mar 1971 · North Dakota
Uniform Controlled Substances Act approved
Prohibited
Official source
16 Apr 1971 · Mississippi
Uniform Controlled Substances Law baseline
Prohibited
Official source
21 Jun 1971 · Maine
Marijuana prohibition statutory baseline
Prohibited
Official source
1 Sep 1971 · Oklahoma
Schedule I marijuana prohibition
Prohibited
Official source
1972 · Louisiana
Controlled Dangerous Substances Law baseline
Prohibited
Official source
1972 · Kentucky
Controlled Substances Act baseline
Prohibited
Official source
1972 · Wisconsin
Controlled-substances prohibition baseline
Prohibited
Official source
1972 · Kansas
Schedule I cannabis baseline
Prohibited
Official source
1972 · California
State controlled-substances prohibition
Prohibited
Official source
1972 · Pennsylvania
State controlled-substances prohibition
Prohibited
Official source
1972 · New Mexico
State controlled-substances prohibition
Prohibited
Official source
1972 · Hawaii
State controlled-substances prohibition
Prohibited
Official source
1973 · Florida
Florida controlled-substance possession prohibition
Prohibited
Official source
1973 · New York
State controlled-substances prohibition
Prohibited
Official source
5 Oct 1973 · Oregon
First state to decriminalise small possession
Decriminalized
Official source
1974 · Rhode Island
Controlled-substances prohibition baseline
Prohibited
Official source
1974 · Georgia
Georgia Controlled Substances Act
Prohibited
Official source
27 May 1975 · Alaska
Ravin v. State protects home possession
Decriminalized
Official source
1 Jul 1975 · Colorado
Small possession made a petty offence
Decriminalized
Official source
21 Nov 1975 · Ohio
Small possession made a minor misdemeanour
Decriminalized
Official source
1 Jan 1976 · California
Moscone Act reduces small possession penalty
Decriminalized
Official source
1976 · Maine
Personal possession decriminalization
Decriminalized
Official source
1976 · Minnesota
Small-amount possession decriminalized
Decriminalized
Official source
1976 · Indiana
State controlled-substances prohibition
Prohibited
Official source
1 Jul 1977 · North Carolina
Small possession made a no-jail misdemeanour
Decriminalized
Official source
29 Jul 1977 · New York
Marihuana Reform Act of 1977
Decriminalized
Official source
1978 · Michigan
State controlled-substances prohibition
Prohibited
Official source
5 Aug 1981 · District of Columbia
Uniform Controlled Substances Act possession prohibition
Prohibited
Official source
1989 · Texas
Controlled-substances prohibition baseline
Prohibited
Official source
1996 · California
Compassionate Use Act approved
Medical only
Official source
3 Dec 1998 · Washington
Initiative 692 medical marijuana
Medical only
Official source
3 Dec 1998 · Oregon
Measure 67 Oregon Medical Marijuana Act
Medical only
Official source
4 Mar 1999 · Alaska
Ballot Measure 8 medical marijuana
Medical only
Official source
Nov 1999 · Maine
Limited medical cannabis law
Medical only
Official source
1 Jun 2000 · Colorado
Amendment 20 medical marijuana
Medical only
Official source
14 Jun 2000 · Hawaii
Act 228 medical marijuana
Medical only
Official source
1 Oct 2001 · Nevada
Medical marijuana law (Question 9 / AB 453)
Medical only
Official source
2004 · Vermont
Medical cannabis patient registry
Medical only
Official source
2 Nov 2004 · Montana
I-148 Medical Marijuana Act
Medical only
Official source
3 Jan 2006 · Rhode Island
Medical Marijuana Act
Medical only
Official source
1 Jul 2007 · New Mexico
Lynn and Erin Compassionate Use Act
Medical only
Official source
4 Dec 2008 · Michigan
Michigan Medical Marihuana Act
Medical only
Official source
2 Jan 2009 · Massachusetts
Question 2 civil penalty for small possession
Decriminalized
Official source
Jul 2010 · New Jersey
Compassionate Use Medical Marijuana Act
Medical only
Official source
27 Jul 2010 · District of Columbia
Medical marijuana program law effective
Medical only
Official source
14 Dec 2010 · Arizona
Proposition 203 Medical Marijuana Act
Medical only
Official source
1 Jul 2011 · Delaware
Delaware Medical Marijuana Act
Medical only
Official source
1 Jul 2011 · Connecticut
Small-quantity marijuana possession decriminalized
Decriminalized
Official source
1 Oct 2012 · Connecticut
Medical marijuana program enacted
Medical only
Official source
6 Dec 2012 · Washington
Initiative 502 adult-use legalization
Legal, including sales
Official source
10 Dec 2012 · Colorado
Amendment 64 adult-use legalisation
Legal, including sales
Official source
1 Jan 2013 · Massachusetts
Question 3 medical marijuana
Medical only
Official source
1 Apr 2013 · Rhode Island
Small-possession decriminalization
Decriminalized
Official source
6 Jun 2013 · Vermont
Civil penalties for small possession
Decriminalized
Official source
23 Jul 2013 · New Hampshire
Therapeutic cannabis law (HB 573)
Medical only
Official source
1 Oct 2013 · Maryland
Academic medical-center cannabis program
Medical only
Official source
1 Jan 2014 · Illinois
Compassionate Use of Medical Cannabis Pilot Program Act
Medical only
Official source
10 Apr 2014 · Kentucky
Cannabidiol exception — low-THC only
Medical only
Official source
18 Apr 2014 · Wisconsin
Lydia’s Law — low-THC only
Medical only
Official source
16 May 2014 · Tennessee
Clinical-research cannabis oil — low-THC only
Medical only
Official source
29 May 2014 · Minnesota
Medical cannabis program enacted
Medical only
Official source
2 Jun 2014 · South Carolina
Julian’s Law — low-THC only
Medical only
Official source
1 Jul 2014 · Utah
Hemp extract registration — low-THC only
Medical only
Official source
1 Jul 2014 · Iowa
Medical Cannabidiol Act — low-THC only
Medical only
Official source
5 Jul 2014 · New York
Compassionate Care Act
Medical only
Official source
17 Jul 2014 · District of Columbia
Personal marijuana possession decriminalized
Decriminalized
Official source
28 Aug 2014 · Missouri
Hemp-extract patient protection — low-THC only
Medical only
Official source
1 Oct 2014 · Maryland
Small-quantity marijuana possession becomes civil
Decriminalized
Official source
24 Feb 2015 · Alaska
Ballot Measure 2 adult-use legalisation
Legal, including sales
Official source
26 Feb 2015 · Virginia
Epilepsy oil affirmative defense — low-THC only
Medical only
Official source
26 Feb 2015 · District of Columbia
Initiative 71 effective
Legal, including sales
Official source
16 Apr 2015 · Georgia
Haleigh's Hope Act — low-THC only
Medical only
Official source
4 May 2015 · Tennessee
Epilepsy cannabis oil exception — low-THC only
Medical only
Official source
1 Jun 2015 · Texas
Compassionate-Use Act — low-THC only
Medical only
Official source
1 Jul 2015 · Wyoming
Hemp extract registration — low-THC only
Medical only
Official source
1 Jul 2015 · Oregon
Measure 91 personal possession and cultivation effective
Legal, including sales
Official source
18 Dec 2015 · Delaware
Civil penalty for small possession
Decriminalized
Official source
17 Apr 2016 · Pennsylvania
Medical Marijuana Act signed
Medical only
Official source
29 Jul 2016 · Illinois
Small possession made a civil violation
Decriminalized
Official source
8 Sep 2016 · Ohio
Medical Marijuana Control Program (HB 523)
Medical only
Official source
Nov 2016 · North Dakota
Compassionate Care Act approved by voters
Medical only
Official source
9 Nov 2016 · Arkansas
Amendment 98 medical marijuana
Medical only
Official source
9 Nov 2016 · California
Proposition 64 Adult Use of Marijuana Act
Legal, including sales
Official source
15 Dec 2016 · Massachusetts
Adult personal possession and cultivation legalized
Legal, including sales
Official source
1 Jan 2017 · Nevada
Question 2 adult-use legalisation
Legal, including sales
Official source
3 Jan 2017 · Florida
Amendment 2 medical marijuana
Medical only
Official source
30 Jan 2017 · Maine
Adult personal possession legalized
Legal, including sales
Official source
19 Apr 2017 · West Virginia
Medical Cannabis Act signed
Medical only
Official source
16 Sep 2017 · New Hampshire
Civil violation for small possession (HB 640)
Decriminalized
Official source
1 Jul 2018 · Vermont
Adult possession and home cultivation
Legal, including sales
Official source
26 Jul 2018 · Oklahoma
State Question 788 medical marijuana
Medical only
Official source
3 Dec 2018 · Utah
Utah Medical Cannabis Act
Medical only
Official source
6 Dec 2018 · Michigan
Michigan Regulation and Taxation of Marihuana Act
Legal, including sales
Official source
20 Dec 2018
Agriculture Improvement Act decontrols hemp
Regulated framework
Official source
2019 · Kansas
Claire and Lola’s Law — low-THC only
Medical only
Official source
1 Jul 2019 · New Mexico
SB 323 civil penalty for small possession
Decriminalized
Official source
1 Aug 2019 · North Dakota
Small-quantity possession reduced to an infraction
Decriminalized
Official source
1 Jan 2020 · Illinois
Cannabis Regulation and Tax Act
Legal, including sales
Official source
11 Jan 2020 · Hawaii
Act 273 decriminalisation
Decriminalized
Official source
1 Jul 2020 · Virginia
Simple-possession civil penalty
Decriminalized
Official source
30 Nov 2020 · Arizona
Proposition 207 Smart and Safe Arizona Act
Legal, including sales
Official source
1 Jan 2021 · Montana
I-190 adult-use legalisation
Legal, including sales
Official source
22 Feb 2021 · New Jersey
Adult-use cannabis legalization
Legal, including sales
Official source
22 Feb 2021 · New Jersey
Marijuana possession decriminalized
Decriminalized
Official source
31 Mar 2021 · New York
Marihuana Regulation and Taxation Act
Legal, including sales
Official source
17 May 2021 · Alabama
Medical Cannabis Act signed
Medical only
Official source
29 Jun 2021 · New Mexico
Adult-use possession and cultivation legalized
Legal, including sales
Official source
1 Jul 2021 · Virginia
Adult personal possession legalized
Legal, including sales
Official source
1 Jul 2021 · Connecticut
Adult-use possession legalised (SB 1201)
Legal, including sales
Official source
1 Jul 2021 · South Dakota
Initiated Measure 26 medical cannabis
Medical only
Official source
2 Feb 2022 · Mississippi
Mississippi Medical Cannabis Act (SB 2095)
Medical only
Official source
25 May 2022 · Rhode Island
Rhode Island Cannabis Act
Legal, including sales
Official source
8 Dec 2022 · Missouri
Adult-use constitutional legalization
Legal, including sales
Official source
23 Apr 2023 · Delaware
Adult-use possession legalised (HB 1)
Legal, including sales
Official source
1 Jul 2023 · Maryland
Adult-use cannabis legalization
Legal, including sales
Official source
1 Aug 2023 · Minnesota
Adult-use personal possession legalized
Legal, including sales
Official source
7 Dec 2023 · Ohio
Issue 2 adult-use legalisation
Legal, including sales
Official source
12 Dec 2024 · Nebraska
Medical cannabis initiatives enacted
Medical only
Official source

Show on the Cannabis map

Kratom

Legal, including sales

Not specifically regulated by state law. Federal law does not list kratom as a scheduled controlled substance in this record; FDA has stated kratom is not lawful as a dietary supplement or conventional food ingredient. Law text: "The FDA is specifically targeting 7-OH, a concentrated byproduct of the kratom plant; it is not focused on natural kratom leaf products."

FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers

25 Apr 2014 · Wisconsin
Wisconsin kratom alkaloid scheduling takes effect
Prohibited
Official source
1 Jan 2015 · Illinois
Illinois Kratom Control Act takes effect
Regulated framework
Official source
10 May 2016 · Alabama
Alabama kratom alkaloid ban takes effect
Prohibited
Official source
15 Jul 2017 · Vermont
Vermont scheduling ban documented in 2017 rule
Prohibited
Official source
1 Jul 2018 · Tennessee
Tennessee natural-form kratom safeguards take effect
Regulated framework
Official source
1 Aug 2018 · Minnesota
Minnesota kratom age restrictions take effect
Regulated framework
Official source
2019 · Georgia
Georgia enacts kratom age and labeling controls
Regulated framework
Official source
2019 · Nevada
Nevada enacts kratom consumer protections
Regulated framework
Official source
14 May 2019 · Utah
Utah Kratom Consumer Protection Act takes effect
Regulated framework
Official source
27 Aug 2019 · Arizona
Arizona Kratom Consumer Protection Act takes effect
Regulated framework
Official source
3 Mar 2021 · South Dakota
South Dakota enacts age-21 kratom controls
Regulated framework
Official source
24 May 2021 · Oklahoma
Oklahoma enacts Kratom Consumer Protection Act
Regulated framework
Official source
2022 · Colorado
Colorado enacts initial kratom regulation
Regulated framework
Official source
2022 · Oregon
Oregon enacts Kratom Consumer Protection Act
Regulated framework
Official source
23 May 2022 · Arizona
Arizona enacts processor and retailer amendments
Regulated framework
Official source
9 Jun 2023 · West Virginia
West Virginia Select Plant-Derived Regulation Act takes effect
Regulated framework
Official source
1 Jul 2023 · Florida
Florida kratom age restriction takes effect
Regulated framework
Official source
1 Jul 2023 · Oregon
Oregon kratom processor registration begins
Regulated framework
Official source
1 Jul 2023 · Virginia
Virginia kratom consumer protections take effect
Regulated framework
Official source
1 Sep 2023 · Texas
Texas kratom consumer protection law takes effect
Regulated framework
Official source
1 Jul 2024 · Colorado
Colorado delayed product and retail restrictions take effect
Regulated framework
Official source
15 Jul 2024 · Kentucky
Kentucky kratom consumer protection law takes effect
Regulated framework
Official source
1 Oct 2024 · Maryland
Maryland Kratom Consumer Protection Act takes effect
Regulated framework
Official source
1 Nov 2024 · Oklahoma
Oklahoma strengthened consumer protections take effect
Regulated framework
Official source
1 Jan 2025 · Georgia
Georgia expanded kratom controls take effect
Regulated framework
Official source
2025 · South Dakota
South Dakota enacts kratom product standards
Regulated framework
Official source
17 Apr 2025 · Mississippi
Mississippi enacts kratom age restrictions
Regulated framework
Official source
29 May 2025 · Colorado
Colorado Daniel Bregger Act takes effect
Regulated framework
Official source
1 Jul 2025 · Nebraska
Nebraska Kratom Consumer Protection Act becomes operative
Regulated framework
Official source
11 Jul 2025 · South Carolina
South Carolina Kratom Consumer Protection Act takes effect
Regulated framework
Official source
1 Aug 2025 · Louisiana
Louisiana statewide kratom prohibition takes effect
Prohibited
Official source
2026 · Connecticut
Connecticut kratom scheduling becomes operative
Prohibited
Official source
1 Apr 2026 · Rhode Island
Rhode Island Kratom Act regulatory framework takes effect
Regulated framework
Official source
6 May 2026 · Utah
Utah restricts retail kratom to qualifying pure leaf
Regulated framework
Official source
1 Jul 2026 · Wyoming
Wyoming kratom product regulation takes effect
Regulated framework
Official source
1 Aug 2026 · Minnesota
Minnesota kratom minimum age rises to 21
Regulated framework
Official source
28 Aug 2026 · Massachusetts
Massachusetts temporary kratom scheduling takes effect
Prohibited
Official source
4 Sep 2026 · North Dakota
North Dakota enacts restricted pure-leaf framework
Regulated framework
Official source
8 Sep 2026 · Delaware
Delaware Kratom Consumer Protection Act takes effect
Regulated framework
Official source

Show on the Kratom map

7-OH

Legal, including sales

Not specifically regulated by state law. Federally, FDA recommended scheduling certain concentrated 7-OH products in July 2025; DEA retains final scheduling authority and was reviewing the recommendation. No completed federal scheduling action is documented in the cited agency statement. Law text: "The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH) products under the Controlled Substances Act (CSA)."

FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers

1 Sep 2023 · Texas
Texas restricts high-7-OH and synthetic kratom products
Regulated framework
Official source
1 Aug 2025 · Louisiana
Louisiana Act 41 bans kratom including 7-OH
Prohibited
Official source
12 Dec 2025 · Ohio
Ohio emergency rule schedules 7-OH
Prohibited
Official source
6 May 2026 · Utah
Utah 7-OH controls with pure-leaf exemption
Regulated framework
Official source
19 May 2026 · Ohio
Ohio permanent 7-OH scheduling rule takes effect
Prohibited
Official source
1 Jul 2026 · Kansas
Kansas schedules 7-OH and mitragynine
Prohibited
Official source
1 Jul 2026 · Tennessee
Tennessee expands prohibition to natural kratom and 7-OH
Prohibited
Official source

Show on the 7-OH map

Timeline of laws

Reviewed law changes and decided bills, each linked to its official source.

Loading timeline…

Bills

National
HB7091
Expanding Veterans’ Access to Emerging Treatments Act (2026 Session)
1. IntroducedJan 15, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
HB7347
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs. (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 14, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
National
HB4242
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. (2023 Session)
1. IntroducedJun 21, 2023 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
HB2623
Innovative Therapies Centers of Excellence Act of 2025 (2025 Session)
1. IntroducedApr 3, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
SB4031
Innovative Therapies Centers of Excellence Act (119th Congress)
Session: January 3, 2025 – January 3, 2027
1. IntroducedMar 9, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
HB9559
IBOGAINE Act (119th Congress)
Session: January 3, 2025 – January 3, 2027
1. IntroducedJun 30, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
HB3684
Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023 (2023 Session)
1. IntroducedMay 25, 2023 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
H.R. 8000
END 7-OH Act (119th Congress (2025–2026))
1. IntroducedMar 19, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
S. 5383
End Gas Station Heroin Act (119th Congress (2025–2026))
1. IntroducedAug 8, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
H.R. 10272
End Gas Station Heroin Act (119th Congress (2025–2026))
1. IntroducedSep 3, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
National
H.R. 9913
Safe Sips Act of 2026 (119th Congress (2025–2026))
1. IntroducedJul 23, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Arizona
SB1188
approved medications; scheduling; prescription authority (2026 Regular Session)
Session: January 12, 2026 – June 13, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedJun 10, 2026 (done)
3. SignedJun 22, 2026 (done)
4. Law in effectNext step (current)
Arizona
SB1752
Mescaline; possession; sale; commercial use (2026 Session)
1. IntroducedFeb 5, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Arizona
SB1542
Controlled substances; approval; use; research (2026 Session)
1. IntroducedFeb 2, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Arizona
SB1570
psilocybin services; regulation; licensure (2024 Fifty-sixth Legislature 2nd Regular)
Vetoed
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. VetoedJun 18, 2024 (failed)
4. SignedDid not happen (skipped)
5. Law in effectDid not happen (skipped)
Arizona
HB2105
psilocybin research (2024 Fifty-sixth Legislature 2nd Regular)
Did not pass; died when the session ended
1. IntroducedDate TBC (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Arkansas
SB 534
Arkansas Kratom Consumer Protection Act (2025)
Did not pass; died when the session ended
1. IntroducedMar 20, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
California
SB751
Veterans and Former First Responders Research Pilot Program. (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 21, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
California
AB1103
Controlled substances: research. (2025–2026 Regular Session)
Session: December 2, 2024 – August 31, 2026
Enacted
1. IntroducedFeb 20, 2025 (done)
2. PassedSep 9, 2025 (done)
3. SignedOct 10, 2025 (done)
4. Law in effectNext step (current)
California
AB941
Controlled substances: psychedelic-assisted therapy. (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 14, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
California
AB2489
Controlled substances: research. (2026 Session)
1. IntroducedFeb 20, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
California
SB1224
The California Emerging Therapies Research Partnership Act. (2026 Session)
1. IntroducedFeb 19, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
California
SB1012
The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act. (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 5, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
California
AB 1088
Public health: kratom (2025–2026)
1. IntroducedFeb 20, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Colorado
HB1325
Natural Medicine (2026 Regular Session)
Session: January 14, 2026 – May 13, 2026
Enacted
1. IntroducedMar 6, 2026 (done)
2. PassedMay 13, 2026 (done)
3. SignedJun 4, 2026 (done)
4. Law in effectNext step (current)
Colorado
SB031
Use of Prescription Product with Controlled Substance (2026 Session)
Enacted
1. IntroducedJan 22, 2026 (done)
2. PassedApr 6, 2026 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Colorado
HB1344
FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use (2022 Session)
Enacted
1. IntroducedMar 28, 2022 (done)
2. PassedMay 31, 2022 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Colorado
HB1063
FDA-Approved Crystalline Polymorph Psilocybin Use (2025 Session)
Enacted
1. IntroducedJan 8, 2025 (done)
2. PassedMar 26, 2025 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Colorado
SB 25-072
Regulation of Kratom (2025)
Enacted
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Connecticut
SB00191
An Act Concerning the Psychedelic-Assisted Therapy Pilot Program (2026 February Session)
Session: February 4, 2026 – May 6, 2026
Enacted
1. IntroducedFeb 11, 2026 (done)
2. PassedMay 6, 2026 (done)
3. SignedJun 4, 2026 (done)
4. Law in effectJul 1, 2026 (done)
Connecticut
HB05102
An Act Allowing The Use Of Psilocybin For Medicinal And Therapeutic Purposes. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 9, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
HB05297
An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 26, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
SB00855
An Act Concerning Funding For The Psychedelic-assisted Therapy Pilot Program. (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 22, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
HB07065
An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 24, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
HB06734
An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 22, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
HB06146
An Act Concerning The Psychedelic-assisted Therapy Pilot Program. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 18, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
HB06380
An Act Decriminalizing The Possession Of Psilocybin. (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 23, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Connecticut
HB05456
An Act Allowing The Use Of Psilocybin For Medicinal And Therapeutic Purposes. (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 17, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Delaware
HB 332
Kratom Consumer Protection Act (2026)
1. IntroducedMar 26, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Delaware
HS1 for HB332
Kratom Consumer Protection Act — enacted substitute (2026)
Enacted
1. IntroducedJun 11, 2026 (done)
2. PassedDate TBC (done)
3. SignedSep 8, 2026 (done)
4. Law in effectSep 8, 2026 (done)
Delaware
SB 262
Uniform Controlled Substances Act amendments (2026)
1. IntroducedMar 18, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Florida
H0309
Controlled Substances (2026 Session)
1. IntroducedNov 4, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Florida
HB549
Use of Psilocybin for Mental Health Treatment (2021 Regular Session)
Did not pass; died when the session ended
1. IntroducedJan 28, 2021 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Georgia
HB717
Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide (2025–2026 Regular Session)
Session: January 13, 2025 – April 2, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedMar 27, 2026 (done)
3. SignedMay 12, 2026 (done)
4. Law in effectJul 1, 2026 (done)
Georgia
SB631
"Veterans Mental Health Innovations Act"; enact (2026 Session)
Did not pass; died when the session ended
1. IntroducedMar 23, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Georgia
HB1296
Mental health; pilot program to support clinical research of certain veterans and first responders suffering from certain conditions; provide (2026 Session)
1. IntroducedFeb 12, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Georgia
HB382
Controlled substances; Schedule I; psilocybin; revise a provision (2026 Session)
Enacted
1. IntroducedFeb 11, 2025 (done)
2. PassedApr 10, 2026 (done)
3. SignedMay 11, 2026 (done)
4. Law in effectNext step (current)
Hawaii
SR88
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older. (2022 Session)
1. IntroducedMar 11, 2022 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Hawaii
HR206
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SCR133
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SB1042
Relating To Mental Health. (2026 Session)
1. IntroducedJan 17, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Hawaii
SCR171
Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. (2026 Session)
1. IntroducedMar 16, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Hawaii
SB3160
Relating To Psilocybin. (2022 Session)
Did not pass; died when the session ended
1. IntroducedJan 26, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SB1454
Relating To Psilocybin. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 25, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SR3
Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 25, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SR206
Requesting The Department Of Health To Convene A Medicinal Psychedelics Right-to-try Task Force To Explore The Development Of A Program For Qualifying Terminally Ill Patients. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SCR5
Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 25, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SCR215
Requesting The Department Of Health To Convene A Medicinal Psychedelics Right-to-try Task Force To Explore The Development Of A Program For Qualifying Terminally Ill Patients. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SCR100
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older. (2022 Session)
Did not pass; died when the session ended
1. IntroducedMar 11, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
HB2400
Relating To Psilocybin. (2022 Session)
Did not pass; died when the session ended
1. IntroducedJan 26, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
HB1337
Relating To Psilocybin. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 25, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SCR227
Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients. (2022 Session)
Did not pass; died when the session ended
1. IntroducedMar 11, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SR162
Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. (2026 Session)
1. IntroducedMar 16, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Hawaii
SB3199
Relating To Mental Health. (2026 Session)
1. IntroducedJan 28, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Hawaii
SR153
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
HCR202
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
HB 717
Hawaii Kratom Consumer Protection Act (2025–2026)
Did not pass; died when the session ended
1. IntroducedJan 21, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Hawaii
SB 463
Hawaii Kratom Consumer Protection Act (2025–2026)
1. IntroducedDate TBC (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Idaho
H0899
Adds to existing law to establish the Medical Advanced Healing Act. (2026 Session)
1. IntroducedMar 16, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Idaho
SB 1418
Idaho Kratom Consumer Protection and Safety Act (2026)
Did not pass; died when the session ended
1. IntroducedDate TBC (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Illinois
SB2353
CONTROLLED SUB-PSILOCYBIN (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Illinois
SB2184
USE AND RESEARCH-ENTHEOGENS (2026 Session)
1. IntroducedFeb 7, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Illinois
SB2772
Psilocybin Advisory Board (104th General Assembly (2025–2026))
Session: January 8, 2025 – January 13, 2027
1. IntroducedDate TBC (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Illinois
HB2992
HOPE PILOT PROGRAM (2026 Session)
1. IntroducedFeb 6, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Illinois
HB1143
Illinois CURE Act (an act concerning health) (104th General Assembly (2025–2026))
Session: January 8, 2025 – January 13, 2027
1. IntroducedJan 9, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Illinois
HB3215
Illinois Kratom Consumer Protection Act (2025–2026)
1. IntroducedFeb 18, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Iowa
HF978
A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.) (2026 Session)
1. IntroducedMar 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Iowa
HF14
A bill for an act relating to the controlled substance crystalline polymorph psilocybin.(See HF 383.) (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
SF659
Appropriations act including crystalline polymorph psilocybin provisions (91st General Assembly (2025–2026))
Session: January 13, 2025 – May 3, 2026
Enacted
1. IntroducedMay 14, 2025 (done)
2. PassedMay 14, 2025 (done)
3. SignedJun 11, 2025 (done)
4. Law in effectJul 1, 2025 (done)
Iowa
SF2151
A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2026 Session)
1. IntroducedJan 29, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Iowa
HF351
A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 12, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
HF609
A bill for an act relating to the use of certain psychoactive substances under the religious freedom restoration Act. (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 26, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
SSB1241
A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.(See SF 659.) (2025 Session)
Did not pass; died when the session ended
1. IntroducedMay 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
HF240
A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 8, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
HF2085
A bill for an act relating to the production and administration of psilocybin and providing penalties. (2026 Session)
1. IntroducedJan 15, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Iowa
HF383
A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25. (2025 Session)
Vetoed
1. IntroducedFeb 13, 2025 (done)
2. PassedMay 19, 2025 (done)
3. VetoedJun 11, 2025 (failed)
4. SignedDid not happen (skipped)
5. Law in effectDid not happen (skipped)
Iowa
SSB1177
A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 24, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
HF620
A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.) (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 26, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Iowa
HF 2133
Designating kratom as a Schedule I controlled substance (2026)
1. IntroducedJan 21, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Kansas
HB2218
Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. (2026 Session)
1. IntroducedFeb 3, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Kentucky
SB77
An Act relating to ibogaine research in the Commonwealth (2026 Regular Session)
Session: January 6, 2026 – April 15, 2026
Enacted
1. IntroducedJan 13, 2026 (done)
2. PassedDate TBC (done)
3. VetoedApr 13, 2026 (failed)
4. SignedApr 14, 2026 (done)
5. Law in effectNext step (current)
Kentucky
SB240
AN ACT relating to Ibogaine research in the Commonwealth. (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 18, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Louisiana
SB43
Provides relative to psychedelic-assisted therapy (2026 Regular Session)
Session: March 9, 2026 – June 1, 2026
Enacted
1. IntroducedMar 9, 2026 (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectAug 1, 2026 (done)
Maine
LD1914
Resolve, to Establish the Commission to Study Pathways for Creating a Psilocybin Services Program in Maine (2024 Session)
Did not pass; died when the session ended
1. IntroducedMay 9, 2023 (done)
2. PassedApr 3, 2024 (done)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Maine
LD1034
An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 12, 2025 (done)
2. PassedJun 3, 2025 (done)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Maryland
HB427
Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership (2026 Regular Session)
Session: January 14, 2026 – April 13, 2026
Enacted
1. IntroducedJan 22, 2026 (done)
2. PassedApr 10, 2026 (done)
3. SignedApr 28, 2026 (done)
4. Law in effectJul 1, 2026 (done)
Maryland
SB1009
Task Force on Responsible Use of Natural Psychedelic Substances (2024 Session)
Enacted
1. IntroducedFeb 2, 2024 (done)
2. PassedApr 3, 2024 (done)
3. SignedMay 16, 2024 (done)
4. Law in effectNext step (current)
Maryland
HB548
Task Force on Responsible Use of Natural Psychedelic Substances (2024 Session)
Enacted
1. IntroducedJan 24, 2024 (done)
2. PassedApr 4, 2024 (done)
3. SignedMay 16, 2024 (done)
4. Law in effectNext step (current)
Maryland
SB527
Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) (2026 Session)
1. IntroducedFeb 4, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Maryland
HB1477
Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) (2026 Session)
1. IntroducedFeb 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Maryland
SB336
Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership (2026 Session)
Enacted
1. IntroducedJan 23, 2026 (done)
2. PassedApr 3, 2026 (done)
3. SignedApr 28, 2026 (done)
4. Law in effectNext step (current)
Massachusetts
H1726
Relative to criminal disposition of limited psilocybin possession offenses (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H3574
Concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA) (2024 Session)
Did not pass; died when the session ended
1. IntroducedMar 30, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
S1009
Relative to plant medicine (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 16, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
H4986
Relative to therapeutic psilocybin treatment centers (2026 Session)
1. IntroducedJan 28, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H2506
Decriminalizing psilocybin as a treatment for PTSD and certain other conditions (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H4255
Relative to the regulation and taxation of natural psychedelic substances (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 1, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
H1624
Establishing a task force to study equitable access to psilocybin and other entheogenic plants (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H4050
To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof (2026 Session)
Did not pass; died when the session ended
1. IntroducedApr 22, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
H3605
Concerning the legal use of the plant medicine known as psilocybin for therapeutic, spiritual, and medicinal purposes (2024 Session)
Did not pass; died when the session ended
1. IntroducedMar 30, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
H2203
Establishing a pilot program for access to regulated psilocybin (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H2532
Relative to therapeutic psilocybin treatment centers (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
S1113
Relative to removing criminal penalties for limited psilocybin possession (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
S1263
Regulating the safe use of psilocybin (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 16, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
H1858
Relative to removing criminal penalties for limited psilocybin possession (2026 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H4607
REPORT of the SPECIAL JOINT COMMITTEE on INITIATIVE PETITIONS on the INITIATIVE PETITION of SARKO GERGERIAN AND OTHERS FOR THE PASSAGE OF AN ACT RELATIVE TO THE REGULATION AND TAXATION OF NATURAL PSYCHEDELIC SUBSTANCES (see House, No. 4255) (2024 Session)
Did not pass; died when the session ended
1. IntroducedMay 2, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
H1754
Relative to plant medicine (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 16, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Massachusetts
S1400
Authorizing a pilot for the use of psychedelics in licensed treatment facilities (2025 Session)
1. IntroducedFeb 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
H4200
An Act authorizing a pilot for the use of psychedelics in licensed treatment facilities (194th General Court (2025–2026))
Session: January 1, 2025 – January 5, 2027
1. IntroducedMar 27, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Massachusetts
S.1609
An Act concerning the regulation of Kratom (2025–2026)
1. IntroducedDate TBC (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Michigan
HB6020
Health: research; participation in ibogaine clinical trials; provide for (2025–2026 Regular Session)
Session: January 8, 2025 – December 31, 2026
1. IntroducedMay 21, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Michigan
HB4686
Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. (2025 Session)
1. IntroducedJun 25, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Michigan
HB5980
Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. (2024 Session)
Did not pass; died when the session ended
1. IntroducedSep 26, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Michigan
SB0802
Controlled substances: conduct associated with qualified psychoactive substances exempt from criminal penalties in certain circumstances (2025–2026 Regular Session)
Session: January 8, 2025 – December 31, 2026
1. IntroducedFeb 26, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Michigan
SB0499
Controlled substances: penalties; conduct associated with entheogenic plants and fungi; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.). (2023 Session)
Did not pass; died when the session ended
1. IntroducedSep 14, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Michigan
HB4969
Kratom product regulation (2025–2026)
1. IntroducedSep 17, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Michigan
SB1181
Kratom Consumer Protection Act (2025–2026)
1. IntroducedSep 22, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Michigan
HB5537
Prohibit conduct related to kratom (2025–2026)
1. IntroducedDate TBC (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Minnesota
HF4577
Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated. (2026 Session)
1. IntroducedMar 23, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Minnesota
SF1954
Psychedelic medicine task force establishment (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 20, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Minnesota
HF1884
Psychedelic medicine task force established, and report required. (2023 Session)
Enacted
1. IntroducedFeb 16, 2023 (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Minnesota
SF4485
Psilocybin therapeutic use program establishment (2026 Session)
1. IntroducedMar 17, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Minnesota
SF3971
Psilocybin therapeutic use program establishment (2026 Session)
1. IntroducedFeb 26, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Minnesota
HF2699
Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated. (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 24, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Minnesota
SF4204
Psilocybin regulation provisions (2026 Session)
1. IntroducedMar 9, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Minnesota
HF2906
Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated. (2026 Session)
Did not pass; died when the session ended
1. IntroducedMar 27, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Mississippi
HB314
Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of. (2026 Session)
Enacted
1. IntroducedJan 8, 2026 (done)
2. PassedMar 18, 2026 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Mississippi
HB563
Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling. (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 13, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Mississippi
SB2562
Mississippi Veterans PTSD Ibogaine Research Pilot Program; create. (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 19, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Mississippi
SB2056
Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs. (2026 Session)
Enacted
1. IntroducedJan 8, 2026 (done)
2. PassedMar 9, 2026 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Mississippi
SB2561
Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of. (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 19, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Mississippi
HB 1077
Kratom product standards (2025)
1. IntroducedDate TBC (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Missouri
SB768
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2024 Session)
Did not pass; died when the session ended
1. IntroducedJan 3, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
SB90
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 8, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
HB951
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 21, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
HB829
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 9, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
SB1682
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 19, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
SB1767
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 26, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
HB2817
Creates provisions relating to ibogaine treatment (2026 Session)
1. IntroducedJan 7, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Missouri
HB2961
Creates provisions relating to ibogaine treatment (2026 Session)
1. IntroducedJan 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Missouri
HB1643
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)
1. IntroducedJan 7, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Missouri
SB1581
Establishes the "Veterans Mental Health Innovation Act" relating to ibogaine treatment (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 20, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Missouri
HB1717
Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)
1. IntroducedJan 7, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Montana
HB955
Legalize psilocybin use for PTSD/mental illness treatment (2023 Regular Session)
Did not pass; died when the session ended
1. IntroducedMar 27, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Nebraska
LB877
Designate certain substances as controlled substances under the Uniform Controlled Substances Act (109th Legislature, Second Session (2026))
Session: January 7, 2026 – April 17, 2026
Enacted
1. IntroducedJan 8, 2026 (done)
2. PassedFeb 27, 2026 (done)
3. SignedMar 3, 2026 (done)
4. Law in effectNext step (current)
Nebraska
LB72
Change provisions relating to controlled substances schedules under the Uniform Controlled Substances Act (2025 Session)
Enacted
1. IntroducedJan 9, 2025 (done)
2. PassedFeb 7, 2025 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Nevada
SJR10
Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (2025 Regular Session)
Session: February 3, 2025 – June 2, 2025
Enacted
1. IntroducedFeb 26, 2025 (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Nevada
AB378
Creates the Alternative Therapy Pilot Program. (BDR 40-820) (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 10, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Hampshire
HB1772
Relative to prescribing ibogaine for investigational use only and adopting the physician associate licensure compact. (2026 Regular Session)
Session: January 7, 2026 – June 4, 2026
Enacted
1. IntroducedJan 7, 2026 (done)
2. PassedJun 4, 2026 (done)
3. SignedJul 15, 2026 (done)
4. Law in effectSep 13, 2026 (done)
New Hampshire
HB1349
Decriminalizing the possession and use of psilocybin mushrooms. (2022 Session)
Did not pass; died when the session ended
1. IntroducedNov 20, 2021 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Hampshire
HB216
Exempting dimethyltryptamine from the controlled drug act. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 3, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Hampshire
HB1693
Relative to the use of psychedelics for therapeutic purposes. (2024 Session)
Did not pass; died when the session ended
1. IntroducedDec 15, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Hampshire
HB528
Amending the penalties for the possession and use of psilocybin for persons 18 years of age or older. (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Hampshire
HB1796
Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions. (2026 Session)
Did not pass; died when the session ended
1. IntroducedDec 17, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Hampshire
HB1809
Authorizing the medical use of psilocybin through a program established in the department of health and human services. (2026 Session)
1. IntroducedDec 18, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
S3148
"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness. (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 13, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Jersey
S2283
Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. (2024-2025 Legislative Session)
Session: January 9, 2024 – January 13, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. SignedJan 20, 2026 (done)
4. Law in effectNext step (current)
New Jersey
A4911
"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution. (2022 Session)
Did not pass; died when the session ended
1. IntroducedDec 5, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Jersey
A1526
Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 13, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Jersey
A3852
Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 22, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Jersey
S2934
"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution. (2022 Session)
Did not pass; died when the session ended
1. IntroducedJun 23, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Jersey
S1384
Kratom Consumer Protection Act (2026–2027)
1. IntroducedJan 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
A4222
Kratom consumer protection (2026–2027)
1. IntroducedFeb 19, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
A1203
CJ’s Law (2026–2027)
1. IntroducedJan 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
S2271
CJ’s Law (2026–2027)
1. IntroducedJan 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
A1617
CJ’s Law — kratom restrictions (2026–2027)
1. IntroducedJan 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
S301
7-hydroxymitragynine scheduling (2026–2027)
1. IntroducedJan 13, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Jersey
A5359
7-hydroxymitragynine scheduling (2026–2027)
1. IntroducedSep 10, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New Mexico
SB219
Medical Psilocybin Act (2025 Regular Session)
Session: January 21, 2025 – March 22, 2025
Enacted
1. IntroducedDate TBC (done)
2. PassedMar 18, 2025 (done)
3. SignedApr 7, 2025 (done)
4. Law in effectNext step (current)
New Mexico
HB393
Study Use Of Psilocybin For Mental Health (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 13, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Mexico
SM12
Study Psilocybin For Therapeutic Treatments (2024 Session)
Enacted
1. IntroducedFeb 6, 2024 (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
New Mexico
SB410
Crystalline Polymorph Psilocybin Rescheduling (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Mexico
HM58
Study Psilocybin-based Medication Treatment (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New Mexico
HB336
Use Of Fda-approved Psilocybin (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 4, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
A08349
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to ten thousand veterans and first responders from the western region of New York state. (2024 Session)
Did not pass; died when the session ended
1. IntroducedDec 13, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
S01817
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
A10375
Allows the growth, cultivation, and regulated adult use of psilocybin for the treatment of certain health conditions; provides for the certification of support service providers and the licensure of cultivators. (2024 Session)
Did not pass; died when the session ended
1. IntroducedMay 21, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
A06210
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2024 Session)
Did not pass; died when the session ended
1. IntroducedApr 3, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
S06180
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2024 Session)
Did not pass; died when the session ended
1. IntroducedApr 3, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
S8136
Enacts the New York State Kratom Consumer Protection Act (2025)
1. IntroducedDate TBC (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
A03775
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2026 Session)
1. IntroducedJan 30, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
S03520
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2024 Session)
Did not pass; died when the session ended
1. IntroducedJan 31, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
S00495
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2026 Session)
1. IntroducedJan 8, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
A09583
Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program. (2026 Session)
1. IntroducedJan 21, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
S01801
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. (2026 Session)
1. IntroducedJan 13, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
S04664
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. (2026 Session)
1. IntroducedFeb 11, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
A01522
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2026 Session)
1. IntroducedJan 10, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
S07832
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to ten thousand veterans and first responders from the western region of New York state. (2024 Session)
Did not pass; died when the session ended
1. IntroducedDec 20, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
A00628
Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions. (2026 Session)
1. IntroducedJan 8, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
A03581
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2024 Session)
Did not pass; died when the session ended
1. IntroducedFeb 3, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
A03845
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. (2026 Session)
1. IntroducedJan 30, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
A02142
Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions (2025-2026 Legislative Session)
Session: January 8, 2025 – December 31, 2026
1. IntroducedJan 15, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
S05303
Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions (2025-2026 Legislative Session)
Session: January 8, 2025 – December 31, 2026
1. IntroducedFeb 20, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
New York
S08807
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. (2024 Session)
Did not pass; died when the session ended
1. IntroducedMar 14, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
New York
S8925
7-OH product restrictions (2025–2026)
1. IntroducedJan 16, 2026 (done)
2. PassedJun 5, 2026 (done)
3. SignedNext step (current)
4. Law in effect— (upcoming)
North Carolina
S1018
The HEAL Act. (2025-2026 Session)
Session: January 8, 2025 – December 18, 2026
1. IntroducedApr 30, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
North Carolina
S568
Innovative Treatments for Mental Health Act (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 25, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
North Dakota
SB2064
Relating to the scheduling of controlled substances (2025 Regular Session)
Session: January 7, 2025 – May 3, 2025
Enacted
1. IntroducedJan 7, 2025 (done)
2. PassedMar 19, 2025 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Ohio
SB 103
Regulate kratom and hemp-derived products (135th General Assembly)
Did not pass; died when the session ended
1. IntroducedDate TBC (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Oklahoma
HB3834
Oklahoma Breakthrough Therapy Act (2026 Regular Session)
Session: February 2, 2026 – May 15, 2026
Enacted
1. IntroducedJan 15, 2026 (done)
2. PassedMay 6, 2026 (done)
3. SignedMay 12, 2026 (done)
4. Law in effectNext step (current)
Oklahoma
HB3414
Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities. (2022 Session)
Did not pass; died when the session ended
1. IntroducedFeb 7, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Oklahoma
HB3174
Public health; providing for the establishment of statewide investigational new drug applications for psilocybin clinical trials; effective date. (2022 Session)
Did not pass; died when the session ended
1. IntroducedFeb 7, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Oklahoma
HB2107
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date. (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 6, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Oklahoma
HB4293
Controlled dangerous substances; Veterans Mental Health Innovation Act; authorizing certain scientific research and clinical trials related to ibogaine; requiring registration; providing certain immunities; effective date. (2026 Session)
1. IntroducedFeb 2, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Oregon
HB4040
Relating to health care; and declaring an emergency. (2026 Session)
Enacted
1. IntroducedFeb 2, 2026 (done)
2. PassedMar 5, 2026 (done)
3. SignedApr 13, 2026 (done)
4. Law in effectNext step (current)
Oregon
HB4110
Relating to ibogaine; prescribing an effective date. (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 2, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Oregon
SB844
Relating to public health (2025 Regular Session)
Enacted
1. IntroducedDate TBC (done)
2. PassedJun 27, 2025 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Oregon
HB2387
Relating to psilocybin (2025 Regular Session)
Enacted
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Pennsylvania
SB1149
Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control (2025-2026 Regular Session)
Session: January 7, 2025 – November 30, 2026
1. IntroducedJan 23, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Pennsylvania
HB1439
Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control (2025-2026 Regular Session)
Session: January 7, 2025 – November 30, 2026
1. IntroducedMay 12, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Pennsylvania
SB 233
Kratom Consumer Protection Act (2025–2026)
1. IntroducedFeb 4, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Pennsylvania
HB 2058
Kratom product regulation (2025–2026)
1. IntroducedNov 19, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Pennsylvania
SB 899
Kratom product regulation (2025–2026)
1. IntroducedJun 30, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Pennsylvania
HB2421
Psilocybin and psilocybin-assisted therapy research (2021-2022 Regular Session)
Did not pass; died when the session ended
1. IntroducedMar 16, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Pennsylvania
HB1959
Psilocybin research and clinical studies (2021-2022 Regular Session)
Did not pass; died when the session ended
1. IntroducedOct 12, 2021 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Rhode Island
H7047
Amends the current law on controlled substances to permit a person to be in possession of less than one ounce of psilocybin and permits psilocybin to be securely cultivated within a person's residence for personal use. (2024 Session)
Did not pass; died when the session ended
1. IntroducedJan 5, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Rhode Island
H5186
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. (2025 Session)
Did not pass; died when the session ended
1. IntroducedJan 24, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Rhode Island
H7756
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. (2026 Session)
1. IntroducedFeb 12, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Rhode Island
H7925
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations. (2026 Session)
1. IntroducedFeb 27, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
South Carolina
S. 221
South Carolina Kratom Consumer Protection Act (2025–2026)
Enacted
1. IntroducedJan 15, 2025 (done)
2. PassedMay 7, 2025 (done)
3. SignedMay 12, 2025 (done)
4. Law in effectJul 11, 2025 (done)
South Dakota
HB1099
An Act to reschedule crystalline polymorph psilocybin in an FDA-approved drug product as a Schedule IV controlled substance (2026 Regular Session)
Session: January 13, 2026 – March 30, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Tennessee
SB2149
Relative to clinical trials (114th General Assembly (2025-2026))
Session: January 14, 2025 – April 23, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedApr 23, 2026 (done)
3. SignedMay 22, 2026 (done)
4. Law in effectMay 22, 2026 (done)
Tennessee
HB2075
AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials. (2026 Session)
Enacted
1. IntroducedJan 23, 2026 (done)
2. PassedDate TBC (done)
3. SignedMay 27, 2026 (done)
4. Law in effectNext step (current)
Texas
SB2308
Relating to the establishment of a consortium to conduct FDA drug development clinical trials with ibogaine (2025 Regular Session (89th Legislature))
Session: January 14, 2025 – June 2, 2025
Enacted
1. IntroducedMar 11, 2025 (done)
2. PassedJun 1, 2025 (done)
3. SignedJun 11, 2025 (done)
4. Law in effectJun 11, 2025 (done)
Texas
HB4813
Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances. (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 13, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Texas
HB4423
Relating to the establishment of the Psilocybin Research Advisory Council. (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 9, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Texas
SB3005
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 14, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Texas
HB3717
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy. (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 4, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Texas
HB4014
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 7, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Utah
SB0083
Controlled Substance Scheduling Amendments (2026 General Session)
Session: January 20, 2026 – March 6, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Utah
SB0114
Controlled Substances Amendments (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 20, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Utah
SB0200
Psilocybin Recommendation Pilot Program Amendments (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 10, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Utah
HB0390
Veterans PTSD Clinical Research Amendments (2026 Session)
Enacted
1. IntroducedJan 27, 2026 (done)
2. PassedMar 11, 2026 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Vermont
S0114
An act relating to the establishment of the Psychedelic Therapy Advisory Working Group (2024 Session)
Enacted
1. IntroducedMar 1, 2023 (done)
2. PassedMay 10, 2024 (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Vermont
H0439
An act relating to decriminalizing certain chemical compounds found in plants and fungi that are commonly used for medicinal, spiritual, religious, or entheogenic purposes (2023 Session)
Did not pass; died when the session ended
1. IntroducedMar 1, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Vermont
H0371
An act relating to removal of criminal penalties for possessing, dispensing, or selling psilocybin and establishment of the Psychedelic Therapy Advisory Working Group (2023 Session)
Did not pass; died when the session ended
1. IntroducedFeb 24, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Vermont
H0452
An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program (2025 Session)
Did not pass; died when the session ended
1. IntroducedFeb 28, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Vermont
S0106
An act relating to continuing the Psychedelic Therapy Advisory Working Group (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 11, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Vermont
H0859
An act relating to psychedelic therapy and clinical drug development trials (2026 Session)
1. IntroducedFeb 3, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Virginia
HB1347
Board of Pharmacy; regulation of psilocybin. (2026 Regular Session)
Session: January 14, 2026 – March 14, 2026
Enacted
1. IntroducedDate TBC (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)
Virginia
HB1513
Psilocybin; possession or distribution for certain medical purposes permitted, penalty. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 4, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Virginia
SB262
Psilocybin or psilocyn; possession, civil penalty. (2022 Session)
Did not pass; died when the session ended
1. IntroducedJan 11, 2022 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Virginia
SB932
Virginia Psilocybin Advisory Board; established, report. (2023 Session)
Did not pass; died when the session ended
1. IntroducedJan 6, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Virginia
SB1135
Crystalline polymorph psilocybin; regulations for prescribing, etc. (2025 Session)
Vetoed
1. IntroducedJan 7, 2025 (done)
2. PassedFeb 20, 2025 (done)
3. VetoedMar 24, 2025 (failed)
4. SignedDid not happen (skipped)
5. Law in effectDid not happen (skipped)
Virginia
SB379
Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes. (2026 Session)
Enacted
1. IntroducedJan 13, 2026 (done)
2. PassedFeb 26, 2026 (done)
3. SignedApr 6, 2026 (done)
4. Law in effectNext step (current)
Washington
SB5977
Concerning psilocybin services. (2024 Session)
Did not pass; died when the session ended
1. IntroducedJan 8, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Washington
SB5263
Concerning access to psilocybin services by individuals 21 years of age and older. (2023 Session)
Enacted
1. IntroducedJan 11, 2023 (done)
2. PassedApr 20, 2023 (done)
3. SignedMay 9, 2023 (done)
4. Law in effectNext step (current)
Washington
HB2281
Concerning psilocybin services. (2024 Session)
Did not pass; died when the session ended
1. IntroducedJan 10, 2024 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Washington
HB1433
Concerning access to psychedelic substances. (2026 Session)
1. IntroducedJan 20, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Washington
SB5201
Concerning access to psychedelic substances. (2026 Session)
1. IntroducedJan 13, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Washington
SB5204
Concerning ibogaine-assisted therapy. (2026 Session)
1. IntroducedJan 13, 2025 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
Washington
SB5921
Concerning psilocybin. (2026 Session)
1. IntroducedJan 12, 2026 (done)
2. PassedNext step (current)
3. Signed— (upcoming)
4. Law in effect— (upcoming)
West Virginia
SB906
Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations (2026 Regular Session)
Session: January 14, 2026 – March 14, 2026
Enacted
1. IntroducedFeb 10, 2026 (done)
2. PassedMar 14, 2026 (done)
3. SignedMar 27, 2026 (done)
4. Law in effectJun 12, 2026 (done)
West Virginia
HB3344
Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 13, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
West Virginia
HB3343
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration (2025 Session)
Did not pass; died when the session ended
1. IntroducedMar 13, 2025 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
West Virginia
HB4721
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 22, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
West Virginia
HB4640
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration (2026 Session)
Did not pass; died when the session ended
1. IntroducedJan 21, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
West Virginia
HB5588
Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD) (2026 Session)
Did not pass; died when the session ended
1. IntroducedFeb 16, 2026 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
West Virginia
HB4626
Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine (2026 Session)
Vetoed
1. IntroducedJan 21, 2026 (done)
2. PassedMar 12, 2026 (done)
3. VetoedMar 14, 2026 (failed)
4. SignedDid not happen (skipped)
5. Law in effectDid not happen (skipped)
Wisconsin
AB753
Medicinal psilocybin treatment fund and PTSD pilot program (2023-2024 Regular Session)
Did not pass; died when the session ended
1. IntroducedDec 6, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Wisconsin
SB727
Medicinal psilocybin treatment fund and PTSD pilot program (2023-2024 Regular Session)
Did not pass; died when the session ended
1. IntroducedNov 21, 2023 (done)
2. PassedDid not happen (skipped)
3. SignedDid not happen (skipped)
4. Law in effectDid not happen (skipped)
Wyoming
SF0056
Kratom product regulation (2026)
Enacted
1. IntroducedFeb 10, 2026 (done)
2. PassedDate TBC (done)
3. SignedDate TBC (done)
4. Law in effectNext step (current)

States and regions (65)

Prohibited: 26 Decriminalized: 15 Research or task force only: 13 Regulated framework: 3 Medical only: 2 Pending bill: 6

Alabama Prohibited
Alaska Prohibited
Ann Arbor Decriminalized
Arcata Decriminalized
Arizona Research or task force only
Arkansas Prohibited
California Research or task force only
Cambridge Decriminalized
Colorado Regulated framework
Connecticut Research or task force only
Delaware Prohibited
District of Columbia Decriminalized
Easthampton Decriminalized
Florida Prohibited
Georgia Medical only
Hawaii Prohibited
Idaho Prohibited
Illinois Pending bill
Indiana Prohibited
Iowa Prohibited
Kansas Prohibited
Kentucky Research or task force only
Louisiana Medical only
Maine Prohibited
Maryland Research or task force only
Massachusetts Pending bill
Michigan Pending bill
Minnesota Prohibited
Mississippi Research or task force only
Missouri Prohibited
Montana Prohibited
Nebraska Prohibited
Nevada Prohibited
New Hampshire Research or task force only
New Jersey Research or task force only
New Mexico Regulated framework
New York Pending bill
North Carolina Pending bill
North Dakota Prohibited
Northampton Decriminalized
Oakland Decriminalized
Ohio Prohibited
Oklahoma Research or task force only
Olympia Decriminalized
Oregon Regulated framework
Pennsylvania Pending bill
Port Townsend Decriminalized
Rhode Island Prohibited
San Francisco Decriminalized
Seattle Decriminalized
Somerville Decriminalized
South Carolina Prohibited
South Dakota Prohibited
Tennessee Research or task force only
Texas Research or task force only
Utah Research or task force only
Vermont Research or task force only
Virginia Prohibited
Washington Prohibited
Washington, DC Decriminalized
Washtenaw County Decriminalized
West Virginia Prohibited
Wisconsin Prohibited
Wyoming Prohibited
Ypsilanti Decriminalized